Last reviewed · How we verify
Aurase Wound gel
Aurase Wound gel promotes wound healing through the stimulation of cellular processes.
Aurase Wound gel promotes wound healing through the stimulation of cellular processes. Used for Treatment of chronic and acute wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers.
At a glance
| Generic name | Aurase Wound gel |
|---|---|
| Sponsor | SolasCure Limited |
| Drug class | Wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Wound healing |
| Phase | Phase 2 |
Mechanism of action
Aurase Wound gel contains a combination of growth factors and other bioactive molecules that work together to stimulate cellular processes, promoting wound healing and tissue repair.
Approved indications
- Treatment of chronic and acute wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aurase Wound gel CI brief — competitive landscape report
- Aurase Wound gel updates RSS · CI watch RSS
- SolasCure Limited portfolio CI